DEF 14AThe Ballot
Outlook Therapeutics, Inc. files DEF 14A
Filed Jan 27, 2022 · 4y ago · Accession 0001104659-22-008303
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Outlook Therapeutics, Inc.
- Ticker
- OTLK
- CIK
- 1649989
- Form type
- DEF 14A
- Filing date
- Jan 27, 2022
- Report date
- Mar 23, 2022
- Document
- tm223254-1_def14a.htm
- Size
- 1.9 MB